Tibes, Raoul
Borad, Mitesh J.
Dutcus, Corina E.
Reyderman, Larisa
Feit, Kevie
Eisen, Andrew
Verbel, David A.
Von Hoff, Daniel D.
Article History
Received: 9 May 2017
Revised: 14 February 2018
Accepted: 9 April 2018
First Online: 5 June 2018
Competing interests
: RT: Institutional grant for clinical trial support. MJB: Clinical trial support received. CED: Employee of Eisai. LR: Employee of Eisai. KF: Employee of Eisai. AE: Former employee of Eisai. DAV: Employee of Eisai. DDVH: Institutional grant for clinical trials and consultant for Strategia Therapeutics.
: The datasets generated during and/or analysed during the current study are on file with Eisai and not publicly available.
: The study was conducted in accordance with the Declaration of Helsinki. It was approved by an Institutional Review Board/Independent Ethics Committee at each study centre and in accordance with an assurance filed with and approved by the U.S. Department of Health and Human Services.
: All patients provided signed informed consent prior to trial entry.
: This study was funded by Eisai Inc.